These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

283 related items for PubMed ID: 6934089

  • 1. Pharmacokinetics of whole and half Theo-Dur tablets.
    Fagerström PO.
    Eur J Respir Dis Suppl; 1980; 109():62-6. PubMed ID: 6934089
    [Abstract] [Full Text] [Related]

  • 2. Absorption of theophylline from conventional and sustained-release tablets.
    Fagerström PO, Mellstrand T, Svedmyr N.
    Int J Clin Pharmacol Ther Toxicol; 1981 Mar; 19(3):131-8. PubMed ID: 7228455
    [Abstract] [Full Text] [Related]

  • 3. Absorption of sustained-release theophylline tablets.
    Fagerström PO, Heintz L.
    Int J Clin Pharmacol Ther Toxicol; 1983 Jul; 21(7):359-62. PubMed ID: 6885207
    [Abstract] [Full Text] [Related]

  • 4. Absorption of theophylline from conventional and sustained-release tablets.
    Mellstrand T, Svedmyr N, Fagerström PO.
    Eur J Respir Dis Suppl; 1980 Jul; 109():54-60. PubMed ID: 6934088
    [Abstract] [Full Text] [Related]

  • 5. The absolute bioavailability of a new pediatric sustained release theophylline tablet, when given as whole or divided tablets.
    Jonkman JH, van der Boon WJ, Schoenmaker R, Holtkamp A, Thürkow-Luikens AJ.
    Int J Clin Pharmacol Ther Toxicol; 1984 Sep; 22(9):506-10. PubMed ID: 6500770
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Pharmacokinetic comparison of a once-daily and twice-daily theophylline delivery system.
    González MA, Kisicki J, Straughn AB.
    Clin Ther; 1994 Sep; 16(4):686-92. PubMed ID: 7982257
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Comparison of Theolair SR and Theo-Dur tablets.
    Domson JF, Hein EW, Sheen A, Sly RM.
    Ann Allergy; 1979 Oct; 43(4):220-2. PubMed ID: 555598
    [Abstract] [Full Text] [Related]

  • 14. The relation of product formulation to absorption of oral theophylline.
    Weinberger M, Hendeles L, Bighley L.
    N Engl J Med; 1978 Oct 19; 299(16):852-7. PubMed ID: 692577
    [Abstract] [Full Text] [Related]

  • 15. Variations in absorption of theophylline from two sustained-release products.
    Ferrari M, Olivieri M, Barozzi E, Ramponi C.
    Clin Ther; 1986 Oct 19; 8(6):646-54. PubMed ID: 3791362
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Comparative pharmacokinetic analysis of a novel sustained-release dosage form of theophylline in humans.
    Raz I, Bialer M, Salame K, Bar-On H.
    Eur J Clin Pharmacol; 1984 Oct 19; 26(3):401-3. PubMed ID: 6734702
    [Abstract] [Full Text] [Related]

  • 19. Absorption of theophylline from a sustained-release theophylline tablet formulation, Theo-Dur.
    Takagi K, Hasegawa T, Ogura Y, Yamaki K, Suzuki R, Satake T, Imaeda N, Mizukami Y.
    Int J Clin Pharmacol Ther Toxicol; 1987 Oct 19; 25(10):530-5. PubMed ID: 3429057
    [Abstract] [Full Text] [Related]

  • 20. Bioavailability, efficacy, and tolerance of two sustained-release theophylline dosage forms in adult patients with bronchial asthma.
    Trautlein JJ, Demers L, Esler V, Field E.
    Clin Ther; 1981 Oct 19; 4(4):252-62. PubMed ID: 7332913
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.